BiotechTube
Home/Cellectis/André Choulika
AC

André Choulika

Founder, Chief Executive Officer, Chairman

Cellectis

Therapeutic Areas

OncologyGenetic Diseases

Cellectis Pipeline

DrugIndicationPhase
lasme-cel (UCART22)Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL)Phase 2
UCART20x22Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)Phase 1/2a
UCART123Acute Myeloid Leukemia (AML) & Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Phase 1

Leadership Team at Cellectis

BW
Bing Wang
Chief Medical Officer
AH
Axel Hoos
CEO of Cellectis Therapeutics
DS
David Sourdive
EVP, Technical Operations
SD
Stéphane Depil
SVP, Research & Development
View full Cellectis profile